Study of IRX4204 for Treatment of Early Parkinson's Disease

NCT02438215 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Io Therapeutics